The correlation between VEGF overexpression and poor prognosis in HCC appears to be due to VEGF-mediated angiogenesis and potential enhancement of tumor invasiveness, which could be a therapeutic target in HCC. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.